Medical Weight Loss for Reading, Pennsylvania Residents
Reading, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Reading through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Reading Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Reading, Pennsylvania through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Reading patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
In Reading, Pennsylvania, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Downtown and the greater Berks County area, with bilingual Spanish care. Compounded semaglutide and tirzepatide ship directly to your door in Pennsylvania, and a licensed physician reviews every plan before anything is prescribed.
Whether you live in central Reading or its outskirts, you get exactly the same care and the same price. Compounded medication arrives in discreet, cold-pack packaging at your Reading address, usually within days.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Reading patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Reading
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Reading address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Reading
Is there a medical weight loss clinic near Reading?
Our physical clinic is in Costa Mesa, California. We serve Reading, Pennsylvania residents through telehealth, the same physician care from Dr. Sharma by secure video, with compounded medication shipped to your address. Telehealth eligibility is confirmed during the consultation.
Do I need to visit in person from Reading?
No. We offer full telehealth consultations. Your physician review, prescription, and ongoing support are all handled remotely, with compounded medication shipped to your Reading address in cold-pack packaging.
How much does treatment cost for Reading patients?
The same as for every patient nationwide: a $119 physician visit, compounded semaglutide from $166/month (a 90-day program is $499), and compounded tirzepatide from $233/month. Medication is billed separately. HSA and FSA are accepted; Klarna and Affirm are available. There is no distance surcharge.
What areas of Reading do you serve?
We serve patients from across Reading by telehealth, including Downtown and the greater Berks County area, with bilingual Spanish care.
What does treatment cost for Reading patients?
The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Reading.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Reading, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.